{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,2]],"date-time":"2026-11-02T20:21:52Z","timestamp":1793650912445,"version":"4.5.1"},"reference-count":28,"publisher":"American Psychiatric Association Publishing","issue":"3","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["AJP"],"published-print":{"date-parts":[[2002,3,1]]},"DOI":"10.1176\/appi.ajp.159.3.430","type":"journal-article","created":{"date-parts":[[2002,10,11]],"date-time":"2002-10-11T18:20:39Z","timestamp":1034360439000},"page":"430-435","source":"Crossref","is-referenced-by-count":114,"title":["Greater Loss of 5-HT<sub>2A<\/sub> Receptors in Midlife Than in Late Life"],"prefix":"10.1176","volume":"159","author":[{"given":"Yvette I.","family":"Sheline","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mark A.","family":"Mintun","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Stephen M.","family":"Moerlein","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Abraham Z.","family":"Snyder","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"230","reference":[{"key":"R1593CHDGIHHG","doi-asserted-by":"crossref","unstructured":"Gozlan H, Daval G, Verge D, Spampinato U, Fattaccini CM, Gallissot C, El Mestikawy S, Hamon M: Aging associated changes in serotoninergic and dopaminergic pre- and postsynaptic neurochemical markers in the rat brain. Neurobiol Aging 1990; 11:437-449","DOI":"10.1016\/0197-4580(90)90011-N"},{"key":"R1593CHDFDBDD","doi-asserted-by":"crossref","unstructured":"Arranz B, Eriksson A, Mellerup E, Plenge P, Marcusson J: Effect of aging in human cortical pre- and postsynaptic serotonin binding sites. Brain Res 1993; 620:163-166","DOI":"10.1016\/0006-8993(93)90286-V"},{"key":"R1593CHDJJBEI","doi-asserted-by":"crossref","unstructured":"Gross-Isseroff R, Salama D, Israeli M, Biegon A: Autoradiographic analysis of age-dependent changes in serotonin 5-HT2A receptors of the human brain postmortem. Brain Res 1990; 519:223-227","DOI":"10.1016\/0006-8993(90)90081-L"},{"key":"R1593CHDGBAGC","doi-asserted-by":"crossref","unstructured":"Wong D, Wagner H, Dannals R, Links J, Frost J, Ravert H, Wilson A, Rosenbaum A, Gjedde A, Douglass K: Effects of age on dopamine and serotonin receptors measured by positron emission tomography in living human brain. Science 1984; 226:1393-1396","DOI":"10.1126\/science.6334363"},{"key":"atypb1","doi-asserted-by":"crossref","unstructured":"Iyo M, Yamasaki T: The detection of age-related decrease of dopamine D1, D2 and serotonin 5-HT2 receptors in living human brain. Prog Neuropsychopharmacol Biol Psychiatry 1993; 17:415-421","DOI":"10.1016\/0278-5846(93)90075-4"},{"key":"R1593CHDGABCD","doi-asserted-by":"crossref","unstructured":"Baeken C, D\u2019haenen H, Flamen P, Mertens J, Terriere D, Chavatte K, Boumon R, Bossuyt A: 123I-5-I-R91150, a new single-photon emission tomography ligand for 5-HT2A receptors: influence of age and gender in healthy subjects. Eur J Nucl Med 1998; 25:1617-1622","DOI":"10.1007\/s002590050339"},{"key":"R1593CHDEAHIB","doi-asserted-by":"crossref","unstructured":"Meyer JH, Kapur S, Houle S, DaSilva J, Owczarek B, Brown GM, Wilson AA, Kennedy SH: Prefrontal cortex 5-HT2 receptors in depression: an [18F]setoperone PET imaging study. Am J Psychiatry 1999; 156:1029-1034","DOI":"10.1176\/ajp.156.7.1029"},{"key":"R1593CHDBGJCB","doi-asserted-by":"crossref","unstructured":"Rosier A, Dupont P, Peuskens J, Bormans G, Vandenberghe R, Maes M, de Groot T, Schiepers C, Verbruggen A, Mortelmans L: Visualisation of loss of 5-HT2A receptors with age in healthy volunteers using [18F]altanserin and positron emission tomographic imaging. Psychiatry Res Neuroimaging 1996; 68:11-22","DOI":"10.1016\/S0925-4927(96)02806-5"},{"key":"R1593CHDBJJGB","doi-asserted-by":"crossref","unstructured":"Meltzer CC, Smith G, Price JC, Reynolds CF III, Mathis CA, Greer P, Lopresti B, Mintun MA, Pollock BG, Ben-Eliezer D, Cantwell MN, Kaye W, DeKosky ST: Reduced binding of [18F]altanserin to serotonin type 2A receptors in aging: persistence of effect after partial volume correction. Brain Res 1998; 813:167-171","DOI":"10.1016\/S0006-8993(98)00909-3"},{"key":"R1593CHDHCEAC","doi-asserted-by":"crossref","unstructured":"Marcusson JO, Morgan DG, Winblad B, Finch CE: Serotonin-2 binding sites in human frontal cortex and hippocampus: selective loss of S-2A sites with age. Brain Res 1984; 311:51-56","DOI":"10.1016\/0006-8993(84)91397-0"},{"key":"R1593CHDIHDAI","doi-asserted-by":"crossref","unstructured":"D\u2019haenen H, Bossuyt A, Mertens J, Bossuyt-Piron C, Gijsemans M, Kaufman L: SPECT imaging of serotonin2 receptors in depression. Psychiatry Res Neuroimaging 1992; 45:227-237","DOI":"10.1016\/0925-4927(92)90018-Y"},{"key":"R1593CHDCAIEC","unstructured":"Lemaire C, Cantineau R, Guillaume M, Plenevaux A, Christiaens L: Fluorine-18-altanserin: a radioligand for the study of serotonin receptors with PET: radiolabeling and in vivo biologic behavior in rats. J Nucl Med 1991; 32:2266-2272"},{"key":"R1593CHDIAHBE","doi-asserted-by":"crossref","unstructured":"Sheline YI, Sanghavi M, Mintun MA, Gado MH: Depression duration but not age predicts hippocampal volume loss in women with recurrent depression. J Neurosci 1999; 19:5034-5043","DOI":"10.1523\/JNEUROSCI.19-12-05034.1999"},{"key":"R1593CHDBHAED","doi-asserted-by":"crossref","unstructured":"Carmichael S, Price J: Architectonic subdivisions of the orbital and medial prefrontal cortex in the macaque monkey. J Comp Neurol 1994; 346:366-402","DOI":"10.1002\/cne.903460305"},{"key":"R1593CHDGJDDF","doi-asserted-by":"crossref","unstructured":"Gundersen HJG, Bendtsen TF, Korbo N: Some new, simple and efficient stereological methods and their use in pathological research and diagnosis. Acta Pathol Microbiol Scand 1988; 96:379-394","DOI":"10.1111\/j.1699-0463.1988.tb05320.x"},{"key":"R1593CHDHHGAB","unstructured":"Mintun MA, Price JP, Smith GS, Lopresti B, Hartman L, Simpson N, Mathis CA: Quantitative 5-HT2A receptor imaging in man using F-18 altanserin: a new model accounting for labeled metabolites (abstract). J Nucl Med 1996; 37:109P"},{"key":"R1593CHDEHADJ","doi-asserted-by":"crossref","unstructured":"Smith GS, Price JC, Lopresti BJ, Huang Y, Simpson N, Holt D, Mason NS, Meltzer CC, Sweet RA, Nichols T, Sashin D, Mathis CA: Test-retest variability of serotonin 5-HT2A receptor binding measured with positron emission tomography and [18F]altanserin in the human brain. Synapse 1998; 30:380-392","DOI":"10.1002\/(SICI)1098-2396(199812)30:4<380::AID-SYN5>3.3.CO;2-L"},{"key":"R1593CHDEHFDC","doi-asserted-by":"crossref","unstructured":"Tan P, Baldwin R, Van Dyck C, Al-Tikriti M, Roth B, Khan N, Charney D, Innis R: Characterization of radioactive metabolites of 5-HT2A receptor PET ligand [18F]altanserin in human and rodent. Nucl Med Biol 1999; 26:601-608","DOI":"10.1016\/S0969-8051(99)00022-0"},{"key":"R1593CHDHGJGD","doi-asserted-by":"crossref","unstructured":"Pazos A, Probst A, Palacios JM: Serotonin receptors in the human brain, IV: autoradiographic mapping of serotonin-2 receptors. Neuroscience 1987; 21:123-139","DOI":"10.1016\/0306-4522(87)90327-7"},{"key":"R1593CHDEGHHH","doi-asserted-by":"crossref","unstructured":"Biver F, Lotstra F, Monclus M, Dethy S, Damhaut P, Wikler D, Luxen A, Goldman S: In vivo binding of [18F]altanserin to rat brain 5HT2 receptors: a film and electronic autoradiographic study. Nucl Med Biol 1997; 24:357-360","DOI":"10.1016\/S0969-8051(97)00054-1"},{"key":"R1593CHDCEAFB","doi-asserted-by":"crossref","unstructured":"Mintun MA, Raichle ME, Kilbourn MR, Wooten GF, Welch MJ: A quantitative model for the in vivo assessment of drug binding sites with positron emission tomography. Ann Neurol 1984; 15:217-227","DOI":"10.1002\/ana.410150302"},{"key":"R1593CHDGEIEJ","unstructured":"Rousset O, Ma Y, Evans AC: Correction for partial volume effects in PET: principle and validation. J Nucl Med 1998; 39:904-911"},{"key":"R1593CHDBAEFE","doi-asserted-by":"crossref","unstructured":"Murphy DGM, DeCarli C, McIntosh AR, Daly E, Mentis MJ, Pietrini P, Szxzepanik J, Schapiro MB, Grady CL, Horwitz B, Rapoport SI: Sex differences in human brain morphometry and metabolism: an in vivo quantitative magnetic resonance imaging and positron emission tomography study on the effect of aging. Arch Gen Psychiatry 1996; 53:585-594","DOI":"10.1001\/archpsyc.1996.01830070031007"},{"key":"R1593CHDFJHAI","doi-asserted-by":"crossref","unstructured":"Raz N, Gunning FM, Head D, Dupuis JH, McQuain J, Briggs SD, Loken WJ, Thornton AE, Acker JD: Selective aging of the human cerebral cortex observed in vivo: differential vulnerability of the prefrontal gray matter. Cereb Cortex 1997; 7:268-282","DOI":"10.1093\/cercor\/7.3.268"},{"key":"R1593CHDIJFFI","doi-asserted-by":"crossref","unstructured":"Mueller EA, Moore MM, Kerr DCR, Sexton G, Camicioli RM, Howieson DB, Quinn JF, Kaye JA: Brain volume preserved in healthy elderly through the eleventh decade. Neurology 1998; 51:1555-1562","DOI":"10.1212\/WNL.51.6.1555"},{"key":"R1593CHDGBFCJ","doi-asserted-by":"crossref","unstructured":"Lerer B, Gillon D, Lichtenberg P, Gorfine M, Gelfin Y, Shapira B: Interrelationship of age, depression, and central serotonergic function: evidence from fenfluramine challenge studies. Int Psychogeriatr 1996; 8:83-102","DOI":"10.1017\/S1041610296002499"},{"key":"R1593CHDGBAHI","doi-asserted-by":"crossref","unstructured":"Degl\u2019Innocenti A, Agren H, Zachrisson O, Backman L: The influence of prolactin response to d-fenfluramine on executive functioning in major depression. Biol Psychiatry 1999; 46:512-517","DOI":"10.1016\/S0006-3223(98)00325-4"},{"key":"R1593CHDEEHFH","unstructured":"Volkow ND, Gur RC, Wang G-J, Fowler JS, Moberg PJ, Ding Y-S, Hitzemann R, Smith G, Logan J: Association between decline in brain dopamine activity with age and cognitive and motor impairment in healthy individuals. Am J Psychiatry 1998; 155:344-349"}],"container-title":["American Journal of Psychiatry"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/psychiatryonline.org\/doi\/10.1176\/appi.ajp.159.3.430","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,7,30]],"date-time":"2024-07-30T23:02:19Z","timestamp":1722380539000},"score":1,"resource":{"primary":{"URL":"https:\/\/psychiatryonline.org\/doi\/10.1176\/appi.ajp.159.3.430"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2002,3,1]]},"references-count":28,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2002,3,1]]}},"alternative-id":["10.1176\/appi.ajp.159.3.430"],"URL":"https:\/\/doi.org\/10.1176\/appi.ajp.159.3.430","relation":{},"ISSN":["0002-953X","1535-7228"],"issn-type":[{"value":"0002-953X","type":"print"},{"value":"1535-7228","type":"electronic"}],"subject":[],"published":{"date-parts":[[2002,3,1]]}}}